{"id":3810,"date":"2021-12-07T18:28:24","date_gmt":"2021-12-07T18:28:24","guid":{"rendered":"http:\/\/biojam.pt\/?p=3810"},"modified":"2023-09-29T10:25:37","modified_gmt":"2023-09-29T10:25:37","slug":"entrevista-a-carlos-monteiro-ceo-biojam-hg-a-tsf-sobre-o-crescimento-da-empresa-em-tempos-de-pandemia","status":"publish","type":"post","link":"https:\/\/biojam.pt\/en\/2021\/12\/07\/entrevista-a-carlos-monteiro-ceo-biojam-hg-a-tsf-sobre-o-crescimento-da-empresa-em-tempos-de-pandemia\/","title":{"rendered":"Carlos Monteiro (CEO Biojam HG) interviews TSF about the company's growth in times of pandemic"},"content":{"rendered":"<p class=\"wp-block-paragraph\">Carlos Monteiro (CEO of Biojam Holding Group) answered some questions related to the company's growth during the pandemic.<\/p>\n\n\n<p class=\"wp-block-paragraph\">Listen to the full interview here.<\/p>\n\n\n<figure class=\"wp-block-audio\"><audio controls src=\"http:\/\/biojam.pt\/wp-content\/uploads\/2021\/12\/entrevista-tsf-20211207-carlos-monteiro.mp3\"><\/audio><\/figure>\n\n\n<p class=\"wp-block-paragraph\">From new drugs in the oncology field to their export to Spain or Latin America.<\/p>\n\n\n<figure class=\"wp-block-image size-full\"><img fetchpriority=\"high\" decoding=\"async\" width=\"768\" height=\"432\" src=\"http:\/\/biojam.pt\/wp-content\/uploads\/2021\/12\/tsf-negocios-e-empresas.jpg\" alt=\"\" class=\"wp-image-3813\" srcset=\"https:\/\/biojam.pt\/wp-content\/uploads\/2021\/12\/tsf-negocios-e-empresas.jpg 768w, https:\/\/biojam.pt\/wp-content\/uploads\/2021\/12\/tsf-negocios-e-empresas-711x400.jpg 711w, https:\/\/biojam.pt\/wp-content\/uploads\/2021\/12\/tsf-negocios-e-empresas-600x338.jpg 600w\" sizes=\"(max-width: 768px) 100vw, 768px\" \/><\/figure>\n\n\n<p class=\"wp-block-paragraph\"><\/p>","protected":false},"excerpt":{"rendered":"<p>Carlos Monteiro (CEO da Biojam Holding Group) respondeu a algumas quest\u00f5es relacionadas com o crescimento da empresa em tempos de pandemia. Ou\u00e7a aqui a entrevista na integra. Desde novos medicamentos na \u00e1rea da oncologia \u00e0 sua exporta\u00e7\u00e3o para Espanha ou Am\u00e9rica Latina.<\/p>","protected":false},"author":2,"featured_media":3811,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[22],"tags":[54,33,51],"class_list":["post-3810","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias-externas","tag-biojam","tag-biojam-holding-group","tag-tsf"],"_links":{"self":[{"href":"https:\/\/biojam.pt\/en\/wp-json\/wp\/v2\/posts\/3810","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/biojam.pt\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/biojam.pt\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/biojam.pt\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/biojam.pt\/en\/wp-json\/wp\/v2\/comments?post=3810"}],"version-history":[{"count":1,"href":"https:\/\/biojam.pt\/en\/wp-json\/wp\/v2\/posts\/3810\/revisions"}],"predecessor-version":[{"id":4297,"href":"https:\/\/biojam.pt\/en\/wp-json\/wp\/v2\/posts\/3810\/revisions\/4297"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/biojam.pt\/en\/wp-json\/wp\/v2\/media\/3811"}],"wp:attachment":[{"href":"https:\/\/biojam.pt\/en\/wp-json\/wp\/v2\/media?parent=3810"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/biojam.pt\/en\/wp-json\/wp\/v2\/categories?post=3810"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/biojam.pt\/en\/wp-json\/wp\/v2\/tags?post=3810"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}